Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tohru Takeuchi

Showing results (71-80 of 125) with videos related to

Pageof 13
Sort By:
International Journal of Molecular Sciences|October 14, 2023
Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic PolyangiitisShogo Matsuda, Katsumasa Oe, Takuya Kotani, et al.
The Clinical Respiratory Journal|April 11, 2018
Potential of Krebs von den Lungen-6 as a predictor of relapse in interstitial pneumonia with anti-aminoacyl tRNA synthetase antibodies-positive dermatomyositisKentaro Isoda, Takuya Kotani, Tohru Takeuchi, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|March 2, 2010
[A refractory case of MPO-ANCA-associated vasculitis presented with gastrointestinal ulcer, rapidly progressive glomerular nephritis and pulmonary multiple nodules]Daisuke Wakura, Daisuke Wakaura, Masako Yoneda, et al.
Modern Rheumatology|April 26, 2021
Comparison of therapeutic effects of combination therapy with prednisolone and tacrolimus or azathioprine on progressive interstitial pneumonia with systemic sclerosisTakao Kiboshi, Takuya Kotani, Junichi Konma, et al.
Frontiers in Bioscience (Landmark Edition)|April 28, 2023
The Impact of Early Optimization of Infliximab Blood Concentrations >1 μg/mL on Therapeutic Effectiveness in Rheumatoid ArthritisYuji Nozaki, Takuya Kotani, Tohru Takeuchi, et al.
Modern Rheumatology|February 15, 2018
Efficacy and safety of combination therapy with prednisolone and oral tacrolimus for progressive interstitial pneumonia with systemic sclerosis: A retrospective studyJunichi Konma, Takuya Kotani, Takeshi Shoda, et al.
International Journal of Rheumatic Diseases|December 8, 2023
Aggressive multi-combination therapy for anti-MDA5 antibody-positive dermatomyositis-rapidly progressive interstitial lung diseaseKenichiro Hata, Takuya Kotani, Shogo Matsuda, et al.
Rheumatology (Oxford, England)|July 11, 2022
Examination of nailfold videocapillaroscopy findings in ANCA-associated vasculitisShogo Matsuda, Takuya Kotani, Reiko Wakura, et al.
Frontiers in Immunology|February 4, 2025
Identification of novel clinical subtypes in patients with microscopic polyangiitis using cluster analysis: multicenter REVEAL cohort studyAyana Okazaki, Shogo Matsuda, Takuya Kotani, et al.
Modern Rheumatology|December 29, 2015
Initial limited three-level thin-section computed tomography scorings predict the prognosis of acute/subacute interstitial pneumonia in patients with dermatomyositisTakuya Kotani, Tohru Takeuchi, Yuki Yoshimatsu, et al.
Pageof 13

Showing results (71-80 of 125) with videos related to

Sort By:
Pageof 13
International Journal of Molecular Sciences|October 14, 2023
Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic PolyangiitisShogo Matsuda, Katsumasa Oe, Takuya Kotani, et al.
The Clinical Respiratory Journal|April 11, 2018
Potential of Krebs von den Lungen-6 as a predictor of relapse in interstitial pneumonia with anti-aminoacyl tRNA synthetase antibodies-positive dermatomyositisKentaro Isoda, Takuya Kotani, Tohru Takeuchi, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|March 2, 2010
[A refractory case of MPO-ANCA-associated vasculitis presented with gastrointestinal ulcer, rapidly progressive glomerular nephritis and pulmonary multiple nodules]Daisuke Wakura, Daisuke Wakaura, Masako Yoneda, et al.
Modern Rheumatology|April 26, 2021
Comparison of therapeutic effects of combination therapy with prednisolone and tacrolimus or azathioprine on progressive interstitial pneumonia with systemic sclerosisTakao Kiboshi, Takuya Kotani, Junichi Konma, et al.
Frontiers in Bioscience (Landmark Edition)|April 28, 2023
The Impact of Early Optimization of Infliximab Blood Concentrations >1 μg/mL on Therapeutic Effectiveness in Rheumatoid ArthritisYuji Nozaki, Takuya Kotani, Tohru Takeuchi, et al.
Modern Rheumatology|February 15, 2018
Efficacy and safety of combination therapy with prednisolone and oral tacrolimus for progressive interstitial pneumonia with systemic sclerosis: A retrospective studyJunichi Konma, Takuya Kotani, Takeshi Shoda, et al.
International Journal of Rheumatic Diseases|December 8, 2023
Aggressive multi-combination therapy for anti-MDA5 antibody-positive dermatomyositis-rapidly progressive interstitial lung diseaseKenichiro Hata, Takuya Kotani, Shogo Matsuda, et al.
Rheumatology (Oxford, England)|July 11, 2022
Examination of nailfold videocapillaroscopy findings in ANCA-associated vasculitisShogo Matsuda, Takuya Kotani, Reiko Wakura, et al.
Frontiers in Immunology|February 4, 2025
Identification of novel clinical subtypes in patients with microscopic polyangiitis using cluster analysis: multicenter REVEAL cohort studyAyana Okazaki, Shogo Matsuda, Takuya Kotani, et al.
Modern Rheumatology|December 29, 2015
Initial limited three-level thin-section computed tomography scorings predict the prognosis of acute/subacute interstitial pneumonia in patients with dermatomyositisTakuya Kotani, Tohru Takeuchi, Yuki Yoshimatsu, et al.
Pageof 13